Complement Factor MASP3/MASP1 Antibody (2B11)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-11245
Key Product Details
Species Reactivity
Human
Applications
Immunoassay, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 2B11
Concentration
0.1 mg/ml
Product Specifications
Immunogen
The antibody recognizes the heavy chain common to both MASP-1 and MASP-3.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Complement Factor MASP3/MASP1 Antibody (2B11)
Application
Recommended Usage
Immunoassay
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
For Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10. The antibody does not work in Western blotting of reduced samples.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
0.2 um filtered solution in PBS, 0.1% BSA
Preservative
0.02% Sodium Azide
Concentration
0.1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: Complement Factor MASP3
Long Name
Mannan-binding lectin-Associated Serine Protease 3
Alternate Names
MASP1
Gene Symbol
MASP1
Additional Complement Factor MASP3 Products
Product Documents for Complement Factor MASP3/MASP1 Antibody (2B11)
Product Specific Notices for Complement Factor MASP3/MASP1 Antibody (2B11)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...